Global Action Network For Sickle Cell & Other Inherited Blood Disorders Inc (EIN 922380477) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2022

Legal Domicile

Principal Officer

Iyabode Olanrewaju Tunji-

Phone

4169516981

Tax Period

2025-01-01 to 2025-12-31

Global Action Network For Sickle Cell & Other Inherited Blood Disorders Inc, founded in 2022, is a small nonprofit in the Diseases & Disorders sector that reported $250K in total revenue in fiscal year 2025.

Mission

Through data-driven advocacy, collaboration, and capacity building, we empower healthcare providers and patient organizations to advance disease-specific and cross-disease initiatives, improving outcomes for people living with sickle cell & other inherited blood disorders, regardless of where they are in the world

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $250,000

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $250,000

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $260,894

Other Expenses $260,894

TOTAL EXPENSES $260,894

Year-over-Year Comparison

	2025	2024	Change
Revenue	$250,000	$259,000	0.0%
Expenses	$260,894	$162,838	+0.6%
Net Income	$-10,894	$96,162	-1.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

N/A

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Iyabode Olanrewaju Tunji-Ajayi	CEO	40.00	Officer Director	$0	$0	$0
Sandra Newton	Member	0.00	Officer	$0	$0	$0
Donnell Edward Ivy	Member	0.00	Officer	$0	$0	$0
Riyad Elbard	Member	0.00	Officer	$0	$0	$0
Vicky Danilatou	Member	0.00	Officer	$0	$0	$0
Marimilia Teixeira Pita	Member	0.00	Officer	$0	$0	$0
Mandy Yee Yee Yap	Member	0.00	Officer	$0	$0	$0
Kibet Shikuku	Member	0.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$250,000	$260,894	$138,004	$-10,894
2024	$259,000	$162,838	$134,348	$96,162
2023	$85,000	$23,968	$84,742	$61,032
2022	No data	$25,346	No data	No data

Global Action Network For Sickle Cell & Other Inherited Blood Disorders Inc